Skelid Side Effects
Generic name: tiludronate
Medically reviewed by Drugs.com. Last updated on Sep 4, 2024.
Note: This document provides detailed information about Skelid Side Effects associated with tiludronate. Some dosage forms listed on this page may not apply specifically to the brand name Skelid.
Applies to tiludronate: oral tablet.
Important warnings
This medicine can cause some serious health issues
Take tiludronate with a full glass (6 to 8 ounces) of water. Use only plain water (not mineral water) when taking a tiludronate tablet.
For at least the first 2 hours after taking tiludronate, do not eat or drink anything other than plain water, and do not take any other medicines including vitamins or mineral supplements.
Especially avoid drinking milk or eating dairy products within 2 hours after taking tiludronate. Also avoid taking supplements that contain calcium, magnesium, iron, or aluminum (such as in multivitamins with iron, and in many types of antacids).
Some people using medicines similar to tiludronate have developed bone loss in the jaw, also called osteonecrosis of the jaw. Symptoms may include jaw pain, swelling, numbness, loose teeth, gum infection, or slow healing after injury or surgery involving the gums. You may be more likely to develop osteonecrosis of the jaw if you have cancer or have been treated with chemotherapy, radiation, or steroids. Other conditions associated with osteonecrosis of the jaw include blood clotting disorders, anemia (low red blood cells), and a pre-existing dental problem.
If you need to have any dental work (especially surgery), tell the dentist ahead of time that you are using tiludronate. You may need to stop using the medicine for a short time.
Talk with your doctor about the risks and benefits of using this medication.
Get emergency medical help if you have any of these signs of an allergic reaction while taking tiludronate (the active ingredient contained in Skelid) hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop using tiludronate and call your doctor at once if you have any of these serious side effects:
-
painful or difficult swallowing;
-
severe heartburn, burning pain in your upper stomach, or coughing up blood;
-
severe joint, bone, or muscle pain;
-
jaw pain, numbness, or swelling;
-
severe diarrhea;
-
bone fracture; or
-
a red, blistering, peeling skin rash.
Less serious side effects of tiludronate may include:
-
nausea, vomiting, upset stomach;
-
mild diarrhea; or
-
runny or stuffy nose.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.
For healthcare professionals
Applies to tiludronate: oral tablet.
General adverse events
The most frequently occurring adverse reactions reported were: Diarrhea (9.3%), nausea (9.3%), and dyspepsia (5.3%).[Ref]
Cardiovascular
- Common (1% to 10%): Hypertension, flushing[Ref]
Dermatologic
Endocrine
- Common (1% to 10%): Hyperparathyroidism[Ref]
Gastrointestinal
- Common (1% to 10%): Diarrhea, nausea, dyspepsia, vomiting, flatulence, tooth disorder, abdominal pain, constipation, dry mouth gastritis[Ref]
Genitourinary
- Common (1% to 10%): Urinary tract infection[Ref]
Metabolic
- Common (1% to 10%): Vitamin D deficiency, anorexia[Ref]
Musculoskeletal
- Common (1% to 10%): Arthralgia, back pain, arthrosis, fracture pathological, skeletal pain
- Postmarketing reports: Atypical subtrochanteric and diaphyseal femoral fractures have been reported with bisphosphonate therapy, including this drug[Ref]
Bone, joint, and/or muscle pain, rarely severe and/or incapacitating have been reported.[Ref]
Nervous system
- Common (1% to 10%): Headache, dizziness, paresthesia, vertigo, involuntary muscle contractions, somnolence, nervousness[Ref]
Ocular
- Common (1% to 10%): Cataract, conjunctivitis, glaucoma[Ref]
Other
- Common (1% to 10%): Pain, accidental injury, influenza like symptoms, chest pain, peripheral edema, infection, asthenia, syncope, fatigue[Ref]
Psychiatric
- Common (1% to 10%): Insomnia, anxiety[Ref]
Respiratory
- Common (1% to 10%): Rhinitis, sinusitis, upper respiratory tract infection, coughing, pharyngitis, bronchitis[Ref]
Hypersensitivity
- Rare (less than 0.1%): Stevens-Johnson syndrome[Ref]
References
1. "Product Information. Skelid (tiludronate)." Sanofi Winthrop Pharmaceuticals
2. Lourwood DL (1998) "The pharmacology and therapeutic utility of bisphosphonates." Pharmacotherapy, 18, p. 779-89
3. Cerner Multum, Inc. "UK Summary of Product Characteristics."
4. Cerner Multum, Inc. "Australian Product Information."
5. Roux C, Listrat V, Villette B, Lessana-Leibowitch M, Ethgen D, Pelissier C, Dougados M, Amor B (1992) "Long-lasting dermatological lesions after tiludronate therapy." Calcif Tissue Int, 50, p. 378-80
6. Reginster JY, Lecart MP, Deroisy R, Ethgen D, Zegels B, Franchimont P (1993) "Paget's disease of bone treated with a five day course of oral tiludronate." Ann Rheum Dis, 52, p. 54-7
7. Fraser WD, Stamp TC, Creek RA, Sawyer JP, Picot C (1997) "A double-blind, multicentre, placebo-controlled study of tiludronate in Paget's disease of bone." Postgrad Med J, 73, p. 496-502
More about Skelid (tiludronate)
- Check interactions
- Compare alternatives
- Imprints, shape & color data
- Dosage information
- During pregnancy
- Drug class: bisphosphonates
- Breastfeeding
Patient resources
Related treatment guides
Further information
Skelid side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.